
"The company, via its wholly owned subsidiary Shilpa Biologicals Pvt Ltd (SBPL), has entered into a three year definitive agreement with Dr Reddy's Laboratories for production-supply of the Sputnik V vaccine from its integrated biologics R&D cum manufacturing center at Dharwad, Karnataka," Shilpa Medicare said in a regulatory filing.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3tMCTeg
via
IFTTT
0 comments:
Post a Comment